Group One Trading’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-28,500
Closed -$278K 8916
2021
Q4
$278K Buy
28,500
+28,200
+9,400% +$530K ﹤0.01% 4742
2021
Q3
$10K Sell
300
-10,200
-97% -$326K ﹤0.01% 7515
2021
Q2
$384K Buy
10,500
+3,700
+54% +$143K ﹤0.01% 4516
2021
Q1
$305K Sell
6,800
-5,400
-44% -$251K ﹤0.01% 4561
2020
Q4
$696K Buy
12,200
+6,100
+100% +$362K ﹤0.01% 2974
2020
Q3
$313K Sell
6,100
-2,200
-27% -$108K ﹤0.01% 3284
2020
Q2
$496K Buy
8,300
+7,900
+1,975% +$423K ﹤0.01% 2639
2020
Q1
$16K Sell
400
-11,100
-97% -$616K ﹤0.01% 4359
2019
Q4
$716K Sell
11,500
-24,400
-68% -$1.16M ﹤0.01% 2145
2019
Q3
$1.22M Buy
+35,900
New +$1.06M 0.01% 1587

Other funds holding DCPH

Group One Trading's DCPH Position: Q2 2024 in Review

Group One Trading sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 705 shares — an estimated $11.1K sold.

Group One Trading first reported a position in DCPH in Q3 2018 and held it in 12 quarters. The position peaked at $743K in Q4 2019. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Group One Trading reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Group One Trading sold 705 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $11.1K.
  • Group One Trading first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2018 and held it in 12 quarters.
  • Group One Trading's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $743K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.